西門子(zi)醫療(liao)發布了(le)2023財年(nian)第二季度季報，顯(xian)示設備(bei)營收(shou)(shou)強勁(jing)(jing)增(zeng)長，訂單總額超過營收(shou)(shou)，設備(bei)訂單出貨比(bi)達1.01。影像(xiang)業務(wu)可比(bi)營收(shou)(shou)增(zeng)長12.7%。臨床治療(liao)業務(wu)可比(bi)營收(shou)(shou)取得9.9%的強勁(jing)(jing)增(zeng)長。但由于新冠病毒抗(kang)原快速檢測業務(wu)量(liang)逐漸下(xia)降，體外診斷(duan)業務(wu)可比(bi)營收(shou)(shou)下(xia)降39.0%。西門子(zi)醫療(liao)確認，2023財年(nian)的可比(bi)營收(shou)(shou)預計將增(zeng)長-1%至1%。(醫藥健(jian)聞(wen))